Home LiteratureArticle Details
PMID: 6339405 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.

Infection and immunity ·Vol. 40 ·No. 1 ·1983-04-00 ·Pages 359-68

Agüero ME, Cabello FC

Abstract

To study the relevance of the ColV plasmid and the capsular K1 antigen in the pathogenicity of Escherichia coli, isogenic strains that differ only in these characteristics were constructed. Studies with these variants demonstrated that the presence of the ColV plasmid increased the serum resistance of E. coli. This increase did not depend on the expression of the K1 antigen. This work also demonstrated that the presence of the K1 antigen protects E. coli from the bactericidal activity of serum. Studies using mouse peritoneal macrophages in the presence of normal serum indicated that the presence of K1 antigen protects E. coli from phagocytosis. Similar experiments with the K1(+) strains performed in the presence of anti-K1 antibodies demonstrated that these antibodies opsonized these bacteria very efficiently in the absence of complement. The K1(-)E. coli variants were efficiently phagocytized in the presence of normal human serum and absorbed human serum, indicating that they are able to be opsonized by complement deposited by activation of the alternative pathway of complement. Work using fluorescence microscopy confirmed that the K1(-) strains are able to fix complement in the absence of antibody. It was also found that the presence of the ColV plasmid may interfere with phagocytosis of the E. coli K1 strains and deposition of complement on these cells. To test the relevance of the results of the in vitro experiments for disease, the pathogenicity of the strains was tested in mice. The results showed that the K1 antigen is the main determinant of pathogenicity of these strains and that the presence of ColV can modify the pathogenic potential of the E. coli K1 strains through a mechanism that does not depend on the production of colicin V.

MeSH Terms
Animals Antibodies, Bacterial/physiology Antigens/genetics,immunology Antigens, Bacterial Antigens, Surface Bacteriocin Plasmids Blood Bactericidal Activity Complement Fixation Tests Escherichia coli/genetics,immunology,pathogenicity Escherichia coli Infections/etiology,immunology,microbiology Horses Humans Lethal Dose 50 Male Mice Phagocytosis Plasmids
Chemicals
Antibodies, Bacterial Antigens Antigens, Bacterial Antigens, Surface K antigens
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Agüero M E
Cabello F C
References (47)
47 references, click to expand
  1. Utilization of two distinct modes of replication by a hybrid plasmid constructed in vitro from separate replicons.
    Proc Natl Acad Sci U S A. 1974 Nov;71(11):4556-60 PMID: 4612523
  2. Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G.
    J Exp Med. 1975 Jun 1;141(6):1269-77 PMID: 1092796
  3. Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.
    J Exp Med. 1975 Jun 1;141(6):1278-90 PMID: 1127381
  4. Epidemiology of Escherichia coli K1 in healthy and diseased newborns.
    Lancet. 1975 May 17;1(7916):1099-104 PMID: 49468
  5. Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.
    J Pediatr. 1976 Dec;89(6):892-7 PMID: 792409
  6. Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli.
    J Clin Microbiol. 1977 Dec;6(6):548-50 PMID: 338623
  7. [Production of colicins V and V2 in vitro and in vivo. Study of their inhibitory action on phagocytosis by peritoneal macrophages].
    Rev Can Biol. 1977 Dec;36(4):307-16 PMID: 345370
  8. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.
    Infect Immun. 1978 Jun;20(3):770-5 PMID: 352958
  9. Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity.
    J Immunol. 1978 Dec;121(6):2174-80 PMID: 363940
  10. K-1 antigen of Escherichia coli: epidemiology and serum sensitivity of pathogenic strains.
    Infect Immun. 1978 Oct;22(1):219-24 PMID: 103825
  11. Phagocytic resistance of Escherichia coli K-1 isolates and relationship to virulence.
    J Clin Microbiol. 1978 Dec;8(6):748-55 PMID: 370149
  12. Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide.
    J Exp Med. 1979 Mar 1;149(3):669-85 PMID: 372481
  13. Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis.
    J Med Microbiol. 1979 Feb;12(1):123-30 PMID: 372531
  14. A rapid method for the identification of plasmid desoxyribonucleic acid in bacteria.
    Plasmid. 1978 Sep;1(4):584-8 PMID: 107540
  15. Virulence of Escherichia coli K1 in adults.
    J Infect Dis. 1979 Jan;139(1):106-8 PMID: 374636
  16. Cloned fragments of the plasmid ColV,I-K94 specifying virulence and serum resistance.
    Nature. 1979 Jun 28;279(5716):778-81 PMID: 377103
  17. Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.
    Infect Immun. 1979 Jul;25(1):293-8 PMID: 383617
  18. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
    Infect Immun. 1979 Aug;25(2):603-9 PMID: 385502
  19. Immunization with major outer membrane proteins in experimental salmonellosis of mice.
    Infect Immun. 1979 Sep;25(3):857-62 PMID: 387596
  20. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    J Clin Invest. 1980 Jan;65(1):82-94 PMID: 6985617
  21. Novel iron uptake system specified by ColV plasmids: an important component in the virulence of invasive strains of Escherichia coli.
    Infect Immun. 1979 Dec;26(3):925-32 PMID: 160892
  22. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Scand J Infect Dis. 1979;11(4):291-301 PMID: 93778
  23. Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli.
    Infect Immun. 1980 May;28(2):359-67 PMID: 6995306
  24. Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals.
    Infect Immun. 1980 Jul;29(1):200-6 PMID: 6995336
  25. Characterization of complement resistance in Escherichia coli conferred by the antibiotic resistance plasmid R100.
    J Immunol. 1980 Oct;125(4):1494-8 PMID: 6997381
  26. K-1 antigen content and the presence of an additional sialic acid-containing antigen among bacteremic K-1 Escherichia coli: correlation with susceptibility to opsonophagocytosis.
    Infect Immun. 1980 Sep;29(3):1055-61 PMID: 7000702
  27. Specific inhibition of Escherichia coli ferrienterochelin uptake by a normal human serum immunoglobulin.
    Infect Immun. 1981 Feb;31(2):631-5 PMID: 6452414
  28. Another Colicin V phenotype: in vitro adhesion of Escherichia coli to mouse intestinal epithelium.
    Infect Immun. 1981 Apr;32(1):343-52 PMID: 6111542
  29. Attachment of bacteria to intestinal epithelial cells in diarrhea caused by Escherichia coli strain RDEC-1 in the rabbit: stages and role of capsule.
    J Infect Dis. 1981 Feb;143(2):219-30 PMID: 6163830
  30. Identification of immunogenic outer membrane proteins of Haemophilus influenzae type b in the infant rat model system.
    Infect Immun. 1981 Jun;32(3):1084-92 PMID: 6972915
  31. The association of the O18, K1 and H7 antigens and the Co1V plasmid of a strain of Escherichia coli with its virulence and immunogenicity.
    J Gen Microbiol. 1980 Dec;121(2):387-400 PMID: 7021764
  32. ColV plasmid-specific aerobactin synthesis by invasive strains of Escherichia coli.
    Infect Immun. 1981 Aug;33(2):540-5 PMID: 6456229
  33. Binding of human immunoglobulin G to protein A in encapsulated Staphylococcus aureus.
    Infect Immun. 1981 Sep;33(3):666-72 PMID: 7287175
  34. Dissociation of bactericidal activity from other functions of activated macrophages in exudates induced by thioglycolate medium.
    Infect Immun. 1981 Oct;34(1):274-84 PMID: 6795125
  35. Escherichia coli antibodies in opsonisation and protection against infection.
    J Med Microbiol. 1981 Nov;14(4):381-9 PMID: 7031250
  36. Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV,I-K94.
    Infect Immun. 1982 Feb;35(2):654-9 PMID: 7035371
  37. Immunoprotection of rats against Haemophilus influenzae type B disease mediated by monoclonal antibody against a haemophilus outer-membrane protein.
    Lancet. 1982 Feb 13;1(8268):366-8 PMID: 6120351
  38. Isolation of a temperature-sensitive derivative of RP1.
    Plasmid. 1980 May;3(3):343-7 PMID: 6100900
  39. Effective elimination of drug resistance and sex factors in Escherichia coli by sodium dodecyl sulfate.
    J Bacteriol. 1968 Mar;95(3):1078-89 PMID: 4868353
  40. Transferable drug resistance and other transferable agents in strains of Escherichia coli from two human populations.
    Lancet. 1968 Jun 29;1(7557):1389-93 PMID: 4172987
  41. Impaired opsonic activity but normal phagocytosis in low-birth-weight infants.
    N Engl J Med. 1969 Oct 23;281(17):926-31 PMID: 4185878
  42. Evaluation of a technique for the estimation of serum bactericidal activity against Gram-negative organisms.
    Med Lab Technol. 1972 Jul;29(3):272-9 PMID: 4561824
  43. Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis.
    J Immunol. 1973 Jan;110(1):262-8 PMID: 4346607
  44. Segmental response of the macrophage plasma membrane to a phagocytic stimulus.
    J Exp Med. 1974 Feb 1;139(2):323-36 PMID: 4149357
  45. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.
    N Engl J Med. 1974 May 30;290(22):1216-20 PMID: 4133095
  46. Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis.
    Lancet. 1974 Aug 3;2(7875):246-50 PMID: 4136144
  47. The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.
    Immunology. 1971 May;20(5):767-77 PMID: 4950867
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1983-04-00
Pages
359-68
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC264856
Subset
IM
Grants
NIAID NIH HHS · R01 AI16078 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com